These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 17087302)
1. [Treatment for hypertension with diabetes mellitus]. Shimamoto K; Miura T Nihon Rinsho; 2006 Nov; 64(11):2097-101. PubMed ID: 17087302 [TBL] [Abstract][Full Text] [Related]
2. [Antihypertensive treatment in diabetics]. Katayama S Nihon Rinsho; 2001 May; 59(5):961-5. PubMed ID: 11391999 [TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome: treatment of hypertensive patients. Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215 [TBL] [Abstract][Full Text] [Related]
5. [Blood pressure control in eldery hypertension]. Shimamoto K Nihon Rinsho; 2006 Jan; 64(1):75-80. PubMed ID: 16408451 [TBL] [Abstract][Full Text] [Related]
6. Current status of antihypertensive prescription and associated blood pressure control in Japan. Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149 [TBL] [Abstract][Full Text] [Related]
7. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies]. Katayama S Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740 [No Abstract] [Full Text] [Related]
8. Hypertension management in outpatient visits by diabetic patients. Aparasu RR; Aparasu A Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038 [TBL] [Abstract][Full Text] [Related]
9. [Cerebrovascular disease and diabetic patients with hypertension]. Kawamura T Nihon Rinsho; 2003 Jul; 61(7):1175-80. PubMed ID: 12877081 [TBL] [Abstract][Full Text] [Related]
11. Management of hypertension in peripheral arterial disease: does the choice of drugs matter? Singer DR; Kite A Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152 [TBL] [Abstract][Full Text] [Related]
12. [Principal entity of hypertension version of CKD guide]. Kimura G Nihon Jinzo Gakkai Shi; 2009; 51(4):442-5. PubMed ID: 19601550 [No Abstract] [Full Text] [Related]
13. Antihypertensive drugs and fibrinolytic function. Fogari R; Zoppi A Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of hypertensive patients with impaired glucose tolerance (IGT)]. Yoshida D; Higashiura K; Shimamoto K Nihon Rinsho; 2005 Feb; 63 Suppl 2():533-7. PubMed ID: 15779436 [No Abstract] [Full Text] [Related]
15. [Risk and prevention of diabetic nephropathy]. Ravera M; Re M; Deferrari G G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients. Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495 [TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research]. Rajzer M; Kawecka-Jaszcz K; Wojciechowska W Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858 [TBL] [Abstract][Full Text] [Related]
18. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China]. Guo QH; Pan CY; Qi WH; Lin SY; Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834 [TBL] [Abstract][Full Text] [Related]
19. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension. Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471 [No Abstract] [Full Text] [Related]
20. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]